BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2156203)

  • 21. [The determination of the viral markers of the hepatitis B virus and protein p53 in liver biopsy samples].
    Lörinczi L; Székely E
    Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):161-6. PubMed ID: 9932005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical studies on hepatitis B markers in the liver tissue of patients with hepatocellular carcinoma.
    Hu KQ; Song PH; Hao LJ
    J Tongji Med Univ; 1987; 7(2):117-22. PubMed ID: 2821287
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
    Wang C; Wang W; Lu H
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease.
    Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H
    Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of the HBX gene product-HBxAG in primary hepatocellular carcinoma, tumor-adjacent tissues and serum in 7 cases].
    Lian ZR
    Zhonghua Yi Xue Za Zhi; 1989 Dec; 69(12):701-3. PubMed ID: 2560943
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
    Wong LY; Chan SH; Oon CJ
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):83-6. PubMed ID: 1965408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B core antigen immune complexes in the liver of hepatitis B patients.
    Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J
    Clin Exp Immunol; 1979 Jul; 37(1):15-24. PubMed ID: 385186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
    Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
    Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The localization of hepatitis viruses in tissues.
    Gerber MA; Thung SN
    Int Rev Exp Pathol; 1979; 20():49-76. PubMed ID: 43841
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis B: new diagnostic possibilities].
    Bianchi L; Gudat F
    Bull Schweiz Akad Med Wiss; 1977 May; 33(1-3):125-40. PubMed ID: 195657
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response.
    Jacob JR; Ascenzi MA; Roneker CA; Toshkov IA; Cote PJ; Gerin JL; Tennant BC
    Hepatology; 1997 Dec; 26(6):1607-15. PubMed ID: 9398005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
    Tang YH
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-HBc titer in relation to the etiological role of hepatitis B virus in primary hepatocellular carcinoma.
    Furuta S; Nagata A; Kiyosawa K; Akahane Y; Koike Y; Sahara T; Oda M; Mayumi M; Tsuda F
    Acta Hepatogastroenterol (Stuttg); 1977 Feb; 24(1):3-6. PubMed ID: 192028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.
    Kiyosawa K; Akahane Y; Nagata A; Furuta S
    Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ground-glass cells in hepatocellular carcinoma.
    Stromeyer FW; Ishak KG; Gerber MA; Mathew T
    Am J Clin Pathol; 1980 Sep; 74(3):254-8. PubMed ID: 6251712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of hepatitis B virus surface component in human hepatocellular cancer cells.
    Nayak NC; Sachdeva R; Dhar A; Seth HN
    Indian J Med Res; 1979 Jan; 69():161-7. PubMed ID: 218886
    [No Abstract]   [Full Text] [Related]  

  • 40. [Distribution of HBcAg in tissues of 104 cases of small liver carcinoma].
    Zhang SP
    Zhonghua Bing Li Xue Za Zhi; 1988 Sep; 17(3):195-7. PubMed ID: 2852549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.